Ilia Tikhonov

Johnson & Johnson (United States) — United States

Medicine · Health Sciences

8h-index414citations19works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pregnancy and Medication Impact(7), Inflammatory Bowel Disease(6), Reproductive System and Pregnancy(4), Microscopic Colitis(4), Endometriosis Research and Treatment(3)

Publications19 total

Safety, tolerability, and efficacy of the PD-1 agonist antibody JNJ-67484703 in adults with active rheumatoid arthritis: results of a multicenter, double-blind, placebo-controlled, randomized, multiple-dose phase Ib study
Therapeutic Advances in Musculoskeletal Disease·2025Open Access
Pregnancy outcomes following periconceptional or gestational exposure to ustekinumab: Review of cases reported to the manufacturer's global safety database
Alimentary Pharmacology & Therapeutics·2022· 26 citedOpen Access
Efficacy and Safety of Maintenance Ustekinumab for Ulcerative Colitis Through 3 Years: UNIFI Long-term Extension
Journal of Crohn s and Colitis·2022· 98 citedOpen Access
Safety and use of tetanus-diphtheria-acellular pertussis-5 (Tdap5) vaccine during pregnancy: findings from 11 years of reporting to a pregnancy registry
Human Vaccines & Immunotherapeutics·2021· 3 citedOpen Access
S930 Safety of Ustekinumab Across Approved Adult Indications: Pooled Safety Analysis in Crohn’s Disease, Ulcerative Colitis, Psoriasis, and Psoriatic Arthritis Through up to 5 Years
The American Journal of Gastroenterology·2021· 1 cited
DOP83 Efficacy and Safety of Ustekinumab for Ulcerative Colitis Through 3 Years: UNIFI Long-term Extension
Journal of Crohn s and Colitis·2021
129 SAFETY OF USTEKINUMAB IN IBD: POOLED SAFETY ANALYSIS THROUGH 5 YEARS IN CD AND 2 YEARS IN UC
Gastroenterology·2021· 2 cited
16886 Pregnancy outcomes in women with psoriasis, psoriatic arthritis, Crohn disease and ulcerative colitis treated with ustekinumab
Journal of the American Academy of Dermatology·2020· 2 cited
Ustekinumab is effective and safe for ulcerative colitis through 2 years of maintenance therapy
Alimentary Pharmacology & Therapeutics·2020· 65 citedOpen Access
Safety of Ustekinumab in Inflammatory Bowel Disease: Pooled Safety Analysis of Results from Phase 2/3 Studies
Inflammatory Bowel Diseases·2020· 112 citedOpen Access
Sa1827 PREGNANCY OUTCOMES IN WOMEN WITH PSORIASIS, PSORIATIC ARTHRITIS, CROHN'S DISEASE AND ULCERATIVE COLITIS TREATED WITH USTEKINUMAB
Gastroenterology·2020· 6 cited
Pregnancy Outcomes in Women with Psoriasis, Psoriatic Arthritis, Crohn’s Disease, and Ulcerative Colitis Treated with Ustekinumab
Zeitschrift für Gastroenterologie·2020
P538 Pregnancy outcomes in women with psoriasis, psoriatic arthritis, Crohn’s disease and ulcerative colitis treated with ustekinumab
Journal of Crohn s and Colitis·2020· 10 citedOpen Access
697 Safety of Ustekinumab in Inflammatory Bowel Diseases: Integrated Safety Analysis of Results From Phase 2 and 3 Studies in Crohn's Disease and Ulcerative Colitis
The American Journal of Gastroenterology·2019
Su1799 - Pregnancy Outcomes in Women Exposed to Ustekinumab
Gastroenterology·2018· 16 cited
Respiratory distress in the neonate: Case definition & guidelines for data collection, analysis, and presentation of maternal immunization safety data
Vaccine·2017· 59 citedOpen Access
Neonatal encephalopathy: Case definition & guidelines for data collection, analysis, and presentation of maternal immunisation safety data
Vaccine·2017· 14 citedOpen Access
Recurrent cholestasis in 16 year-old patient
Russian Journal of Gastroenterology Hepatology Coloproctology·2016Open Access
Current algorhytm of screening and early diagnosis of hepatocellular carcinoma
SHILAP Revista de lepidopterología·2014Open Access

Frequent Co-authors

Silvio Danese(7), Colleen Marano(7), William J. Sandborn(6), Sheri Volger(5), Bruce E. Sands(5), Christopher D. O’Brien(4), Elyssa Ott(4), Christopher Gasink(4), Anja Geldhof(4), Yiying Zhou(3), Subrata Ghosh(3), María T. Abreu(3), David Rowbotham(3), Remo Panaccione(3), Tadakazu Hisamatsu(3), Ellen Scherl(3), Rupert W. Leong(3), Ramesh Arasaradnam(3), Connie B. Lin(3), Brian G. Feagan(2)